Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans

Eukaryotic Cell

Volumn 4, Issue 2, 2005, Pages 465-475

  Bryan, R A ^a   Zaragoza, O ^a   Zhang, T ^a   Ortiz, G ^a   Casadevall, A ^a   Dadachova, E ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; BACTERIAL POLYSACCHARIDE; DIMETHYL SULFOXIDE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; MONOCLONAL ANTIBODY; SOLVENT; SORBITOL;

ARTICLE; BACTERIAL MEMBRANE; CELL SURVIVAL; CHEMISTRY; CRYPTOCOCCUS NEOFORMANS; CYTOLOGY; DRUG EFFECT; GAMMA RADIATION; HUMAN; METABOLISM; RADIATION EXPOSURE; ULTRASTRUCTURE;

ANTIBODIES, MONOCLONAL; ANTIOXIDANTS; ASCORBIC ACID; BACTERIAL CAPSULES; CELL SURVIVAL; CRYPTOCOCCUS NEOFORMANS; DIMETHYL SULFOXIDE; GAMMA RAYS; HUMANS; INDICATORS AND REAGENTS; POLYSACCHARIDES, BACTERIAL; SOLVENTS; SORBITOL;

FILOBASIDIELLA NEOFORMANS; FUNGI; LETHRINIDAE;

EID: 13844315858     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.4.2.465-475.2005     Document Type: Article

References (38)

1. Bergman, F. 1965. Studies on capsule synthesis of Cryptococcus neoformans. Sabouraudia 4:23-31.
2. Bhattacharjee, A. K., J. E. Bennett, and C. P. J. Glaudemans. 1984. Capsular poly-saccharides of Cryptococcus neoformans. Rev. Infect. Dis. 6:619-624.
3. Bose, I., A. J. Reese, J. J. Ory, G. Janbon, and T. L. Doering. 2003. A yeast under cover: the capsule of Cryptococcus neoformans. Eukaryot. Cell. 4:655-663.
4. Brooks, S. E., and D. L. Schneider. 1985. Oxidative metabolism associated with phagocytosis in Acanthamoeba castellanii. J. Protozool. 32:330-333.
5. Casadevall, A., E. Dadachova, and L. Pirofski. 2004. Passive antibody therapy for infectious diseases. Nat. Rev. Microbiol. 2:695-703.
6. Casadevall, A., and J. R. Perfect. 1998. Cryptococcus neoformans, p. 147-151. ASM Press, Washington, D.C.
7. Casadevall, A., M. DeShaw, M. Fan, F. Dromer, T. R. Kozel, and L. A. Pirofski. 1994. Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan. Infect. Immun. 62:3864-3872.
8. Chang, Y. C., and K. J. Kwong-Chung. 1994. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol. Cell. Biol. 14:4912-4919.
9. Cherniak, R., Morris, L. C., Anderson, B. C., and S. A. Meyer. 1991. Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans. Infect. Immun. 59:59-64.
10. Cherniak, R., and J. B. Sundstrom. 1994. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect. Immun. 62:1507-1512.
11. Cleare, W., and A. Casadevall. 1999. Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release. Med. Mycol. 37:235-243.
12. Cruickshank, J. G., R. Cavill, and M. Jelbert. 1973. Cryptococcus neoformans of unusual morphology. Appl. Microbiol. 25:309-312.
13. Dadachova, E., T. Burns, R. A. Bryan, C. Apostolidis, M. W. Brechbiel, J. D. Nosanchuk, A. Casadevall, and L. Pirofski. 2004. Feasibility of radioimmunotherapy of experimental pneumococcal infection. Antimicrob. Agents Chemother. 48:1624-1629.
14. Dadachova, E., R. W. Howell, R. A. Bryan, A. Frenkel, J. D. Nosanchuk, and A. Casadevall. 2004. Susceptibility of human pathogens Cryptococcus neoformans and Histoplasma capsulatum to gamma radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes. J. Nucl. Med. 45:313-320.
15. Dadachova, E., A. Nakouzi, R. Bryan, and A. Casadevall. 2003. Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection, Proc. Natl. Acad. Sci. USA 100:10942-10947.
16. Dembitzer, H. M., I. Buza, and F. Reiss. 1973. Biological and electron microscopic changes in gamma-radiated Cryptococcus neoformans. Mycopathol. Mycol. Appl. 47:307-315.
17. Doering, T. L. 2000. How does Cryptococcus get its coat? Trends Microbiol. 8:547-553.
18. Dubois, M., K. A. Gilles, J. K. Hamilton, P. A. Rebers, and F. Smith. 1956. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28:350-356.
19. Garcia-Rivera, J., Chang, Y. C., Kwon-Chung, K. J., and A. Casadevall. 2004. Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuro-noxylomannan. Eukaryot. Cell 3:385-392.
20. Gates, M. A., P. Thorkildson, and T. R. Kozel. 2004. Molecular architecture of the Cryptococcus neoformans capsule. Mol. Microbiol. 52:13-24.
21. Goren, M. B., and G. M. Middlebrook. 1967. Protein conjugates of polysaccharide from Crypto-coccus neoformans. J. Immunol. 98:901-913.
22. Hall, E. 2000. Radiobiology for a radiologist. Lippincott, Philadelphia, Pa.
23. Ikeda, R., and T. Maeda. 2004. Structural studies of the capsular polysaccharide of a non-neoformans Cryptococcus species identified as C. laurentii, which was reclassified as Cryptococcus flavescens, from a patient with AIDS. Carbohydr. Res. 339:503-509.
24. Kozel, T. R., and C. A. Hermerath. 1984. Binding of cryptococcal polysaccharide to Cryptococcus neoformans. Infect. Immun. 43:879-886.
25. Lengeler, K. B., G. M. Cox, and J. Heitman. 2001. Serotype AD strains of Cryptococcus neoformans are diploid or aneuploid and are heterozygous at the mating-type locus. Infect. Immun. 69:115-122.
26. Love, G. L., G. D. Boyd, and D. L. Greer. 1985. Large Cryptococcus neoformans isolated from brain abscess. J. Clin. Microbiol. 22:1068-1070.
27. Morelli, R., S. Russo-Volpe, N. Bruno, and R. Lo Scalzo. 2003. Fenton-dependent damage to carbohydrates: free radical scavenging activity of some simple sugars. J. Agric. Food Chem. 51:7418-7425.
28. Mukherjee, J., W. Cleare, and A. Casadevall. 1995. Monoclonal antibody mediated capsular reactions (quellung) in Cryptococcus neoformans. J. Immunol. Methods 184:139-143.
29. Reese, A. J., and T. L. Doering. 2003. Cell wall alpha-1,3-glucan is required to anchor the Cryptococcus neoformans capsule. Mol. Microbiol. 50:1401-1409.
30. Sharpatyi, V. A. 1999. Radiochemistry of polysaccharides. Radiat. Biol. Radioecol. 39:156-161.
31. Sorenson, J. A., and M. E. Phelps. 1987. Physics in nuclear medicine. W. B. Saunders Company, Philadelphia, Pa
32. Steenbergen, J. N., H. A. Shuman, and A. Casadevall. 2001 Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc. Natl. Acad. Sci. USA 98:15245-15250.
33. Subramanian, M., G. J. Chintalwar, and S. Chattopadhyay. 2002. Antioxidant properties of a Tinospora cordifolia polysaccharide against iro-mediated lipid damage and gamma-ray induced protein damage. Redox Rep. 7:137-143.
34. van den Hoogen, B. M., P. R. van Weeren, M. Lopes-Cardozo, L.M. van Golde, A. Barneveld, and C. H. van de Lest. 1998. A microtiter plate assay for the determination of uronic acids. Anal. Biochem. 257:107-111.
35. York, W. S., A. G. Darvill, M. McNeil, T. T. Stevenson, and P. Albersheim. 1985. Isolation and characterization of plant cell walls and cell wall components. Methods Enzymol. 118:3-40.
36. Zaragoza, O., and A. Casadevall. 2004. Experimental modulation of capsule size in Cryptococcus neoformans. Biol. Proc. 6:10-15.
37. 2. Infect. Immun. 71:6155-6164.
38. Zaragoza, O., C. Taborda, and A. Casadevall. 2003. The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions. Eur. J. Immunol. 33:1957-1967.